Becton Dickinson/$BDX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Becton Dickinson
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
Ticker
$BDX
Sector
Primary listing
NYSE
Employees
74,000
Headquarters
Website
Becton Dickinson Metrics
BasicAdvanced
$54B
34.29
$5.47
0.22
$4.07
2.22%
Price and volume
Market cap
$54B
Beta
0.22
52-week high
$251.99
52-week low
$163.33
Average daily volume
2.1M
Dividend rate
$4.07
Financial strength
Current ratio
1.103
Quick ratio
0.453
Long term debt to equity
68.825
Total debt to equity
75.93
Dividend payout ratio (TTM)
74.07%
Interest coverage (TTM)
5.71%
Profitability
EBITDA (TTM)
5,919
Gross margin (TTM)
47.16%
Net profit margin (TTM)
7.41%
Operating margin (TTM)
16.37%
Effective tax rate (TTM)
15.92%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
3.98%
Return on equity (TTM)
6.17%
Valuation
Price to earnings (TTM)
34.289
Price to revenue (TTM)
2.529
Price to book
2.11
Price to tangible book (TTM)
-4.93
Price to free cash flow (TTM)
21.214
Free cash flow yield (TTM)
4.71%
Free cash flow per share (TTM)
8.842
Dividend yield (TTM)
2.17%
Forward dividend yield
2.22%
Growth
Revenue change (TTM)
7.86%
Earnings per share change (TTM)
12.91%
3-year revenue growth (CAGR)
4.10%
10-year revenue growth (CAGR)
8.56%
3-year earnings per share growth (CAGR)
-1.80%
10-year earnings per share growth (CAGR)
3.12%
3-year dividend per share growth (CAGR)
5.77%
10-year dividend per share growth (CAGR)
5.67%
What the Analysts think about Becton Dickinson
Analyst ratings (Buy, Hold, Sell) for Becton Dickinson stock.
Bulls say / Bears say
The Waters merger adds about $4 billion in debt and increases organizational complexity just as proposed U.S. government cuts to basic research threaten nearly half of BD’s 2024 revenue, which comes from biosciences. This heightens both execution and demand risks ([Reuters](source turn2news12)).
BD shares dropped 2.3% in premarket trading after the Reverse Morris Trust merger with Waters was announced, reflecting investor skepticism over the deal’s valuation and the challenges of integration ([Reuters](source turn11news13)).
Selling off the Biosciences & Diagnostic Solutions division eliminates a unit that accounted for roughly 45% of BD’s 2024 revenue. This could reduce steady revenue streams and limit future growth in higher-margin diagnostics businesses ([Reuters](source turn2news12)).
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Becton Dickinson Financial Performance
Revenues and expenses
Becton Dickinson Earnings Performance
Company profitability
Becton Dickinson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept30
Becton Dickinson
DividendPayment
$1.04Per share
FAQs
What’s the current market cap for Becton Dickinson stock?
Becton Dickinson (BDX) has a market cap of $54B as of September 19, 2025.
What is the P/E ratio for Becton Dickinson stock?
The price to earnings (P/E) ratio for Becton Dickinson (BDX) stock is 34.29 as of September 19, 2025.
Does Becton Dickinson stock pay dividends?
Yes, the Becton Dickinson (BDX) stock pays dividends to shareholders. As of September 19, 2025, the dividend rate is $4.07 and the yield is 2.22%. Becton Dickinson has a payout ratio of 74.07% on a trailing twelve-month basis.
When is the next Becton Dickinson dividend payment date?
The next Becton Dickinson (BDX) dividend payment is scheduled for September 30, 2025.
What is the beta indicator for Becton Dickinson?
Becton Dickinson (BDX) has a beta rating of 0.22. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.